<PAGE> 2                      
                           UNITED STATES
                SECURITIES AND EXCHANGE COMMISSION
                    Washington, D.C. 20549

                          FORM 10-QSB

[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
      OF THE SECURITIES AND EXCHANGE ACT OF 1934
For the Quarter ended July 31, 1997

[ ]   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE 
      EXCHANGE ACT
For the transition period    to 

Commission file number     -    0-25614

                GLOBUS CELLULAR & USER PROTECTION, LTD.
                (formerly Leridges International, Inc.)
            (Exact name of Small Business Issuer in its charter)

           NEVADA                                       88-0228274
(State or other jurisdiction of                     (I.R.S. Employer
incorporation or organization)                     Identification No.)


      1980 Windsor Road
Kelowna, British Columbia, Canada                        V1Y 4R5
(Address of principal executive offices)                (Zip Code)

Registrant's Telephone number, including area code:    (604) 860-3130

Indicate by check mark whether the Registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities and Exchange 
Act of 1934 during the preceding twelve months (or such shorter period that 
the Registrant was required to file such reports), and (2) has been subject to 
file such filing requirements for the past thirty days.

Yes    x      No
    -------        --------

Indicate the number of shares outstanding of each of the issuer's classes of 
common stock, as of the close of the period covered by this report:

                4,095,515 Shares of Common Stock ($.001 par value)
                           (Title of Class)

Transitional Small Business Disclosure Format (check one):      
Yes          No   x
   -------     --------  












<PAGE> 3
                        GLOBUS CELLULAR & USER PROTECTION LTD.



PART I:  Financial Information

         ITEM 1 - Financial statements

         ITEM 2 - Management's' discussion and analysis of 
         financial condition and results of operations

PART II: Other Information

         ITEM 6 - Exhibits and Reports on Form 8-K












<PAGE> 4
                                            PART I

Item 1. Financial Statements:

                               Globus Cellular and User Protection Ltd.
                                          Balance Sheet
                                          July 31, 1997
<TABLE>
<CAPTION>
                           ASSETS
<S>                                                          <C>
Current assets:
  Cash                                                    $ 18,659
  Accounts receivable, trade                                13,733
  Accounts receivable, other                                 7,559
  Inventories                                               76,279
  Prepaid expenses                                           5,000
  Prepaid expenses - related party                           3,119
                                                         ---------
      Total current assets                                 124,350

Property and equipment, at cost, less
  accumulated depreciation of $38,397                       45,071

Other assets                                                 1,804
                                                          --------
                                                          $171,226
                                                          ========

            LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
  Accounts payable                                        $ 16,758
  Loans from stockholders                                  141,757
                                                          --------
      Total current liabilities                            158,515


Stockholders' equity:
 Preferred stock, $.001 par value,
  20,000,000 shares authorized,                                  -
 Common stock, $.001 par value,
  100,000,000 shares authorized,
  4,095,515 shares issued and
  outstanding                                                4,276
 Additional paid-in capital                              2,321,622
 Stock subscriptions                                       206,430
 Foreign exchange adjustment                                (3,487)
 (Deficit)                                              (2,516,130)
                                                         ---------
                                                            12,710
                                                         ---------
                                                         $ 171,226
                                                         =========
</TABLE>


See accompanying notes to financial statements.


<PAGE>5


             Globus Cellular and User Protection Ltd.
                  Statements of Operations
       Three Months and Mine Months Ended July 31, 1997 and 1996
<TABLE>
<CAPTION>

                                              Three Months        Three Months        Nine Months        Nine Months
                                                 Ended               Ended               Ended               Ended
                                                July 31,            July 31,            July 31,           July 31,
                                                 1997                1996                1997                1996
                                              --------            --------             --------            --------
<S>                                              <C>                  <C>                <C>                 <C>
Sales                                         $    14,323         $   516,860         $   74,177         $   563,368
Cost of sales                                       5,392             176,799             46,556             208,462
                                              -----------         -----------        -----------         -----------
Gross profit (loss)                                 8,931             340,061             27,621             354,906

Other costs and expenses:
 General and administrative                       218,477             331,461            663,362             597,178
 Research and development                           8,984               2,588             28,170               7,178
                                              -----------         -----------        -----------         -----------
                                                  227,460             336,049            691,531             604,356
                                              -----------         -----------        -----------         -----------
Income (loss) from operations                    (218,529)              4,012           (663,910)           (249,450)

Other income and (expense):
 Interest income                                       25                 518                102               1,524
 Gain on sale of building                                                                  5,604
 Other income                                       9,335               5,551             22,897               2,763
 Interest expense                                    (190)             (2,252)            (2,439)             (5,650)
                                              -----------         -----------        -----------         -----------
                                                    9,170               3,817             26,164              (1,633)
                                              -----------         -----------        -----------         -----------
Income (loss) before income taxes                (209,359)              7,829           (637,746)           (251,083)
Provision for income taxes
                                              -----------         -----------        -----------         -----------
  Net income (loss)                         $    (209,359)       $      7,829        $  (637,746)        $  (251,083)
                                              ===========         ===========        ===========         ===========

Earnings (loss) per share:
 Net income (loss)                          $      (0.05)        $     (0.00)        $     (0.16)        $     (0.07)
                                             ===========         ===========         ===========         ===========

 Weighted average shares outstanding           4,223,830           3,578,606           4,074,391           3,390,489
                                             ===========         ===========         ===========         ===========


</TABLE>





See accompanying notes to financial statements.





<PAGE>6
                   Globus Cellular and User Protection Ltd.
                         Statements of Cash Flows
                  Nine Months Ended July 31, 1997 and 1996

<TABLE>
<CAPTION>
                                                 Nine Months         Nine Months
                                                   Ended               Ended
                                                  July 31             July 31
                                                    1997                1996
                                                  --------            --------
<S>                                                <C>                  <C>
Net cash provided by (used in)
 operating activities                           $  (98,267)          $  (95,417)


Cash flows from investing activities:
  Purchase of equipment                            (18,465)             (11,800)
                                               -----------          -----------
  Net cash provided by (used in)
   financing activities                            (18,465)             (11,800)

Cash flows from financing activities:
  Common stock sold for cash                        48,073               96,850
  Increase (repayment) of officer loans             47,309               (9,500)
                                               -----------          -----------
  Net cash provided by (used in)
   financing activities                             95,382               87,350
                                               -----------          -----------
Increase (decrease) in cash                        (21,350)             (19,867)
Cash and cash equivalents,
 beginning of period                                40,009              156,849
                                               -----------          -----------
Cash and cash equivalents,
 end of period                                $     18,659          $   136,982
                                               ===========          ===========
</TABLE>




      See accompanying notes to financial statements.






<PAGE>7

Globus Cellular & User Protection, Ltd.
Notes to Financial Statements


Basis of presentation

The accompanying condensed unaudited financial statements have 
been prepared in accordance with generally accepted accounting 
principles for interim financial information and with the 
instructions to form 10-QSB. Accordingly, they do not include all 
of the information and footnotes required by generally accepted 
accounting principles for complete financial statements. In the 
opinion of management, all adjustments (consisting of normal 
recurring adjustments) considered necessary for a fair 
presentation have been included.

The results of operations for the periods presented are not 
necessarily indicative of the results to be expected for the full 
year. The accompanying financial statements should be read in 
conjunction with the Company's form 10-KSB filed for the year 
ended October 31, 1995.

Income (loss) per share was computed using the weighted average 
number of common shares outstanding.

During the period ended July 31, 1997, the Company issued 1,823 
shares of its common stock pursuant to the exercise of warrants 
for cash aggregating $1,823.  Also, options to purchase 100,000 
shares of the Company's common stock issued to an officer during 
the year ended October 31, 1995 were exercised for cash 
consideration to the Company aggregating $48,073.

In addition, the Company issued 86,190 shares of its common stock 
as compensation to consultants and employees, pursuant to a 
registration statement on Form S-8, filed in January 1996.  The 
shares were valued at the market price of the common stock on the 
date the issuance of shares was authorized.  The aggregate value 
of the shares issued in these transactions was $54,950.  
Additionally, the Company issued restricted common stock as 
compensation to consultants and others for services performed for 
the Company aggregating 50,842 shares valued at $27,725, based on 
the market value of the stock on the grant date.

Form S-8 shares were issued to a financial consultant during the 
year ended October 31, 1996 for a service contract with a two 
year term beginning April 15, 1996.  Shares issued prior to the 
performance of contracted services are accounted for as unpaid 
subscriptions to common stock.  The Company records monthly 
expense of $17,130 related to the services it receives pursuant 
to the contract and reduces the unpaid subscription account by a 
corresponding amount.

During the nine months ended July 31, 1997, two of the Company's 
officers agreed to forego cash payments for salary and technology 
lease payments accrued during the quarter in exchange for common 
stock of the Company.  The restricted shares to be issued to the 
officers in lieu of cash payments of $101,250 were valued at $.22 
per share, an amount equal to one-half of the bid price for the 
Company's common stock on the date the transaction was approved 
by the Company's board of directors.  Additionally one of the 
officers received 110,720 shares of restricted common stock for 
services rendered during the second quarter of the current fiscal 
year and for payment of other amounts due him.  The aggregate 
value of the stock issued was $23,930.

During the quarter ended April 30, 1997, the Company sold its 
interest the building used for its office and warehouse 
activities to its president.  The Company recorded a gain from 
the transaction of $5,604.  Corresponding reductions of mortgage 
indebtedness of $60,960 and amounts due its president of $33,205 
were recorded in connection with the transaction.  The Company 
plans to lease the facility from its president at market rates.








<PAGE> 8

                    GLOBUS CELLULAR & USER PROTECTION LTD.

PART I (cont.)

Item 2. Management's Discussion and Analysis of Financial 
Condition and Results of Operations:

Capital Resources and Liquidity.

The Company completed a private sale of 500,000 common shares for $500,000 
in the third and fourth quarter of fiscal 1995 and has settled all debts, 
including payment on the License of Technology to January 1, 1995.   The 
payment on License of Technology for 1996 and the first six months of 1997 
was made by the issuance of the Company's common stock to Dr. Bickert.   
Additionally, the Company commenced reselling of x-ray products (film, 
shielding garments, x-ray machines and accessories) to generate an immediate 
input of additional revenues.  The Company believes that the proceeds of the 
sale of Common Stock and the exercise of outstanding warrants will be 
sufficient to allow it to operate with minimum revenues over the next twelve 
(12) months.   However, such proceeds will not allow the Company to commence 
full scale operations regarding its planned C.U.P. product.

During the nine months ended July 31, 1997, two of the Company's officers 
agreed to forego cash payments for salary and technology lease payments 
accrued during the quarter in exchange for common stock of the Company.  The 
restricted shares to be issued to the officers in lieu of cash payments of 
$101,250 were valued at $.22 per share, an amount equal to one-half of the 
bid price for the Company's common stock on the date the transaction was 
approved by the Company's board of directors.  Additionally one of the 
officers received 110,720 shares of restricted common stock for services 
rendered during the second quarter of the current fiscal year and for 
payment of other amounts due him.  The aggregate value of the stock issued 
was $23,930.

During the nine months ended July 31, 1997, the Company sold its interest 
the building used for its office and warehouse activities to its president.  
The Company recorded a gain from the transaction of $5,604.  Corresponding 
reductions of mortgage indebtedness of $60,960 and amounts due its president 
of $33,205 were recorded in connection with the transaction.  The Company 
plans to lease the facility from its president at market rates.

Long-term liquidity will be dependent on anticipated future revenue.   
Additionally, the Company shall pursue a registration of its Common Shares 
and Class "A" Warrants and will, in part, rely on the subsequent exercise of 
said Warrants.   Any additional funds raised and any revenues received from 
sale of Company's products will enable Company to expand its plan of 
operations by increasing its production and expanding its product line.

During the nine months ended July 31, 1997, the Company issued 32,049 shares 
of its restricted common stock pursuant to the exercise of warrants for cash 
aggregating $48,073.   Additionally, the Company received additional
shareholder loans ($47,309) resulting in net cash provided by financing 
activities of $95,382 for the nine months ended July 31, 1997.

The Company acquired plant and equipment valued at $18,465 for the nine 
months ended July 31, 1997.   This resulted in net cash used in investing 
activities of $18,465.   The Company does not anticipate purchasing any 
additional plant or significant equipment and does not expect any 
significant changes in the number of its employees, nor does Company expect 
to perform any material product research and development during the next 
twelve (12) months.

During the period ended July 31, 1996, the Company issued 64,567 shares of 
its restricted common stock pursuant to the exercise of warrants for cash 
aggregating $96,850.   Additionally, the Company repaid a portion of its 
shareholder loans ($9,500) resulting in net cash provided by financing 
activities of $87,350 for the nine months ended July 31, 1996.

The Company acquired plant and equipment valued at $11,800 for the period 
ended July 31, 1996.   This resulted in net cash used in investing 
activities of $11,800.   The Company does not anticipate purchasing any 
additional plant or significant equipment and does not expect any 
significant changes in the number of its employees, nor does Company expect 
to perform any material product research and development during the next 
twelve (12) months.

The Company is not presently aware of any known trends, events or 
uncertainties that may have a material impact on net sales, revenues or 
income from its operations.  However, Company's product is new in the market 
and there are not assurances it can be marketed successfully and/or 
profitably.

Results of Operations.

The Company experienced a net loss from operating activities of $98,267 for the 
nine months ended July 31, 1997.   Total Sales were $14,323 for the three 
months ended July 31, 1997 and $74,177 for the nine months ended July 31, 1997.
Cost of Sales, however, were $5,392 and $46,556 for the same periods 
respectively.  Substantial selling, general and administrative expenses of 
$218,477 were incurred for the three months ended July 31, 1997 and $663,362 for

<PAGE>9

the nine months ended July 31, 1997 due to the Company's increased operations.  
The Company expended $8,984 on  research and development expenses for the three 
months ended July 31, 1997 and $28,170 for the nine months ended July 31, 1997
due to the stage of development of the C.U.P. product and commencement of 
sale of said product.   

The Company experienced a net loss from operating activities of $95,417 for the 
nine months ended July 31, 1996.   Total Sales were $516,860 for the three 
months ended July 31, 1996 and $563,368 for the nine months ended July 31, 1996.
Cost of Sales, however, were $238,370 and $270,033 for the same periods 
respectively.  Substantial selling, general and administrative expenses of 
$641,561 were incurred for the three months ended July 31, 1996 and $905,278 for
the nine months ended July 31, 1996 due to the Company's increased operations.  
The Company expended $2,588 on  research and development expenses for the three 
months ended July 31, 1996 and $7,178 for the nine months ended July 31, 1996
due to the stage of development of the C.U.P. product and commencement of 
sale of said product.   









<PAGE>10

                 GLOBUS CELLULAR & USER PROTECTION LTD.

PART II


Item 6. Exhibits and Reports on Form 8-K  

(a)   Exhibits (numbered in accordance with Item 601 of 
      Regulation S-K)

      None

(b)   Reports on Form 8-K

      None










 
                                        SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.




Date:    September 15, 1997           /s/  Dr. Paul F. Bickert
                                      ----------------------------------
                                      Dr. Paul F. Bickert, President